COFCO Biotechnology Co., Ltd. (SHE:000930)
China
· Delayed Price · Currency is CNY 5.54
+0.05 (0.91%)
Apr 3, 2025, 1:45 PM CST
COFCO Biotechnology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | -259.16 | -601.63 | 1,059 | 1,130 | 593.12 | 592.82 | Upgrade
|
| Depreciation & Amortization | 487.63 | 487.63 | 458.19 | 449.81 | 436.4 | 425.28 | Upgrade
|
| Other Amortization | 21.58 | 21.58 | 17.96 | 20.79 | 25.74 | 19.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.16 | -1.16 | 145.82 | 203.22 | 13.98 | 699.46 | Upgrade
|
| Asset Writedown & Restructuring Costs | 54.45 | 54.45 | 13.3 | 21.48 | 27.07 | 9.14 | Upgrade
|
| Loss (Gain) From Sale of Investments | 10.33 | 10.33 | 4.08 | -41.92 | 23.54 | -36.07 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.15 | -0.15 | 0.21 | 0.21 | -0.08 | 0.12 | Upgrade
|
| Other Operating Activities | -868.57 | 641.07 | 278.15 | 347.89 | 416.92 | 268.37 | Upgrade
|
| Change in Accounts Receivable | 1,011 | 1,011 | -1,052 | 2,418 | -2,276 | 960.77 | Upgrade
|
| Change in Inventory | 679.83 | 679.83 | 83.07 | 760.34 | -2,462 | 983.4 | Upgrade
|
| Change in Accounts Payable | -287.46 | -287.46 | -329.12 | -414.53 | 270.69 | -272.96 | Upgrade
|
| Change in Other Net Operating Assets | -14.35 | -14.35 | -6.27 | 8.67 | 23.57 | 0.13 | Upgrade
|
| Operating Cash Flow | 790.81 | 1,958 | 708.44 | 4,842 | -2,911 | 3,650 | Upgrade
|
| Operating Cash Flow Growth | 136.12% | 176.38% | -85.37% | - | - | - | Upgrade
|
| Capital Expenditures | -455.8 | -634.52 | -565.78 | -1,110 | -987.52 | -900.76 | Upgrade
|
| Sale of Property, Plant & Equipment | 18.53 | 166.32 | 246.92 | 270.39 | 102.11 | 151.7 | Upgrade
|
| Divestitures | - | - | - | 160.52 | - | - | Upgrade
|
| Investment in Securities | - | - | 5.6 | - | - | 86.42 | Upgrade
|
| Other Investing Activities | -32.17 | -104.8 | 12.68 | 10.96 | -13.62 | 32.28 | Upgrade
|
| Investing Cash Flow | -469.44 | -572.99 | -300.58 | -667.9 | -899.03 | -630.36 | Upgrade
|
| Long-Term Debt Issued | - | 7,565 | 6,437 | 8,253 | 9,440 | 6,170 | Upgrade
|
| Long-Term Debt Repaid | - | -7,275 | -6,521 | -11,627 | -5,566 | -8,895 | Upgrade
|
| Net Debt Issued (Repaid) | -241.94 | 289.33 | -84.59 | -3,374 | 3,873 | -2,725 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 89.15 | - | Upgrade
|
| Common Dividends Paid | -92.58 | -1,172 | -554.75 | -277.34 | -164.35 | -196 | Upgrade
|
| Other Financing Activities | -115.98 | 2.91 | 45.05 | -50.03 | -43.61 | -169.39 | Upgrade
|
| Financing Cash Flow | -450.49 | -880.04 | -594.28 | -3,702 | 3,755 | -3,090 | Upgrade
|
| Foreign Exchange Rate Adjustments | 61.24 | 11.07 | 40.37 | -4.32 | -0.54 | 1.42 | Upgrade
|
| Net Cash Flow | -67.88 | 516.02 | -146.05 | 467.69 | -55.84 | -69.18 | Upgrade
|
| Free Cash Flow | 335.01 | 1,323 | 142.66 | 3,732 | -3,898 | 2,749 | Upgrade
|
| Free Cash Flow Growth | - | 827.69% | -96.18% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1.61% | 6.49% | 0.72% | 15.84% | -19.58% | 14.12% | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.72 | 0.08 | 2.02 | -2.10 | 1.49 | Upgrade
|
| Cash Income Tax Paid | 316.7 | 214.77 | 227.63 | 603.27 | 229 | 412.27 | Upgrade
|
| Levered Free Cash Flow | 272.14 | 1,273 | 192.1 | 3,071 | -4,424 | 1,417 | Upgrade
|
| Unlevered Free Cash Flow | 337.8 | 1,343 | 246.55 | 3,170 | -4,365 | 1,518 | Upgrade
|
| Change in Net Working Capital | -387.3 | -1,727 | 618.38 | -2,756 | 4,339 | -1,603 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.